日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Porphyromonas gingivalis Membrane protein insertase YidC (yidC), partial CSB-YP353001EYA1
CSB-EP353001EYA1
CSB-BP353001EYA1
CSB-MP353001EYA1
CSB-EP353001EYA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Naja sagittifera Phospholipase A2 isoform 1 CSB-YP353002NAO
CSB-EP353002NAO
CSB-BP353002NAO
CSB-MP353002NAO
CSB-EP353002NAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio vulnificus Nucleoid-associated protein VVA0877 (VVA0877) CSB-YP353003VCQ
CSB-EP353003VCQ
CSB-BP353003VCQ
CSB-MP353003VCQ
CSB-EP353003VCQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arginine/agmatine antiporter (adiC), partial CSB-YP353004EGX
CSB-EP353004EGX
CSB-BP353004EGX
CSB-MP353004EGX
CSB-EP353004EGX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorate reductase subunit beta (clrB) CSB-YP353005IAF
CSB-EP353005IAF
CSB-BP353005IAF
CSB-MP353005IAF
CSB-EP353005IAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus UPF0291 protein SA1176 (SA1176) CSB-YP353006SKY
CSB-EP353006SKY
CSB-BP353006SKY
CSB-MP353006SKY
CSB-EP353006SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant UPF0291 protein spyM18_1699 (spyM18_1699) CSB-YP353007SMU
CSB-EP353007SMU
CSB-BP353007SMU
CSB-MP353007SMU
CSB-EP353007SMU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Magnolia grandiflora Ribosomal protein S12, mitochondrial (RPS12) CSB-YP353008MAZ
CSB-EP353008MAZ
CSB-BP353008MAZ
CSB-MP353008MAZ
CSB-EP353008MAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Photorhabdus luminescens subsp. laumondii 50S ribosomal protein L11 (rplK) CSB-YP353009PIJ
CSB-EP353009PIJ
CSB-BP353009PIJ
CSB-MP353009PIJ
CSB-EP353009PIJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio vulnificus Formimidoylglutamase (hutG) CSB-YP353010VCQ
CSB-EP353010VCQ
CSB-BP353010VCQ
CSB-MP353010VCQ
CSB-EP353010VCQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Petunia hybrida ATP synthase subunit 9, mitochondrial (ATP9), partial CSB-YP353011EUD1
CSB-EP353011EUD1
CSB-BP353011EUD1
CSB-MP353011EUD1
CSB-EP353011EUD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Atropa belladonna Photosystem II reaction center protein L (psbL), partial CSB-YP353012AQX
CSB-EP353012AQX
CSB-BP353012AQX
CSB-MP353012AQX
CSB-EP353012AQX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Photosystem II reaction center protein L (psbL), partial CSB-YP353013OFG
CSB-EP353013OFG
CSB-BP353013OFG
CSB-MP353013OFG
CSB-EP353013OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesembryanthemum crystallinum Photosystem II reaction center protein L (psbL), partial CSB-YP353014MRC
CSB-EP353014MRC
CSB-BP353014MRC
CSB-MP353014MRC
CSB-EP353014MRC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spinacia oleracea Photosystem II reaction center protein L (psbL), partial CSB-YP353015FKI
CSB-EP353015FKI
CSB-BP353015FKI
CSB-MP353015FKI
CSB-EP353015FKI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Parabuthus villosus Potassium channel toxin alpha-KTx 11.2 CSB-YP353016PBW
CSB-EP353016PBW
CSB-BP353016PBW
CSB-MP353016PBW
CSB-EP353016PBW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Agelenopsis aperta Mu-agatoxin-Aa1c CSB-YP353017AER
CSB-EP353017AER
CSB-BP353017AER
CSB-MP353017AER
CSB-EP353017AER-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Adapter protein mecA (mecA) CSB-YP353018SKY
CSB-EP353018SKY
CSB-BP353018SKY
CSB-MP353018SKY
CSB-EP353018SKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Ribonuclease Z (rnz) CSB-YP353019SKX
CSB-EP353019SKX
CSB-BP353019SKX
CSB-MP353019SKX
CSB-EP353019SKX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tityus obscurus Potassium channel toxin alpha-KTx 18.1 CSB-YP353020TET
CSB-EP353020TET
CSB-BP353020TET
CSB-MP353020TET
CSB-EP353020TET-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×